The Lancet Rheumatology, 4(6), e417-e429. Lancet Publishing Group The Lancet. Rheumatology, 4, e417-e429 T2B! immunity against SARS-CoV-2 study group 2022, ' Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants : a substudy of two prospective cohort studies ', The Lancet Rheumatology, vol. 4, no. 6, pp. e417-e429 . https://doi.org/10.1016/S2665-9913(22)00102-3 The Lancet Rheumatology, 4(6), E417-E429. ELSEVIER The Lancet. Rheumatology, 4, 6, pp. e417-e429 The Lancet. Rheumatology, 4(6), e417-e429. Elsevier Ltd The Lancet Rheumatology, 4(6), e417-e429. Elsevier
The Lancet Rheumatology, 4(5), e338-e350. Elsevier The Lancet. Rheumatology, 4(5), e338-e350. Elsevier Ltd The Lancet Rheumatology, 4(5), E338-E350. ELSEVIER T2B! immunity against SARS-CoV-2 study group 2022, ' Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants : a cohort study ', The Lancet Rheumatology, vol. 4, no. 5, pp. e338-e350 . https://doi.org/10.1016/S2665-9913(22)00034-0 The Lancet Rheumatology, 4(5), e338-e350. Lancet Publishing Group The Lancet Rheumatology, 4(5), E338-E350. Lancet Publishing Group
The Lancet (London), 396, 10263, pp. 1653-1662 The Lancet, 396(10263), 1653-1662. Elsevier Limited The Lancet (London), 396, 1653-1662 The Lancet, 396(10263), 1653-1662. Elsevier Ltd. Lancet, Vol. 396, no. 10263, p. 1653-1662 (2020) Jochmans, I, Brat, A, Davies, L, Hofker, H S, van de Leemkolk, F E M, Leuvenink, H G D, Knight, S R, Pirenne, J, Ploeg, R J & COMPARE Trial Collaboration and Consortium for Organ Preservation in Europe (COPE) 2020, ' Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE) : a randomised, double-blind, paired, phase 3 trial ', The Lancet, vol. 396, no. 10263, pp. 1653-1662 . https://doi.org/10.1016/S0140-6736(20)32411-9 LANCET, 396(10263), 1653-1662. ELSEVIER SCIENCE INC